This course equips heart transplant and VAD selection committee members with tools to apply consistent, equitable, and collaborative decision-making practices. Participants will explore multidisciplinary criteria, identify systemic inequities, and align with CMS requirements through case-based learning and peer discussion. This education prepares them to make transparent, bias-aware decisions that support fair access to advanced heart failure therapies.
Course Director:
- Joseph Mishkin, MD | Advocate Health
Overall Objectives:
- Evaluate multidisciplinary criteria for advanced heart therapy candidacy
- Analyze inequities in transplant selection/decision-making
- Integrate collaborative decision-making in compliance with CMS requirements
Target Audience:
This activity is designed for physicians, nurses, physician assistants, and other healthcare professionals.

Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Medical Association (AMA)
Advocate Health designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Advocate Health designates this live activity for a maximum of 0.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of Physician Associates (AAPA)
Advocate Health has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Facebook
X
LinkedIn
Forward